Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients

Renal Failure

Volumn 27, Issue 2, 2005, Pages 213-219

  Shi, Xue Feng ^a  

^a NONE

Author keywords

Ascorbic acid; Hemodialysis; Oxidative stress

Indexed keywords

ASCORBIC ACID; CHOLESTEROL; IRON; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SUCROSE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ATTENUATION; BIOCHEMISTRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSATE; DISEASE EXACERBATION; EXTRACORPOREAL CIRCULATION; FEMALE; HEMODIALYSIS; HUMAN; IN VIVO STUDY; LONG TERM EXPOSURE; MAINTENANCE THERAPY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UREMIA; VITAMIN BLOOD LEVEL;

ASCORBIC ACID; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEMODIALYSIS SOLUTIONS; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS;

EID: 15344349434     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200049533     Document Type: Article

References (10)

1. Witko-Sarsat, V.; Friedlander, M.; Capeillére-Blandin, C.; et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996, 49 (5), 1304-1313.
2. Miyata, T.; van Ypersele de Strihou, C.; Kurokawa, K.; Baynes, J.W. Alterations in non-enzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999, 55 (2), 389-399.
3. Miyata, T.; Kurokawa, K.; van Ypersele de Strihou, C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int. 2000, 76 (Suppl.), S120-S125.
4. Hassan, M.Q.; Hussain, S.A.; Zaki, M.A.; Alsharif, N.Z.; Stohs, S.J. Prospective effects of antioxidants against uraemia-induced lipid peroxidation and glutathione depletion in humans. Pharmacol. Toxicol. 1995, 77 (6), 407-411.
5. Tarng, D.C.; Wei, Y.H.; Huang, T.P.; Kuo, B.I.; Yang, W.C. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int. 1999, 55 (6), 2477-2486.
6. Morena, M.; Cristol, J.P.; Bosc, J.Y.; et al. Convective and diffusive losses of vitamin C during haemodiafiltration sessions: a contributive factor to oxidative stress in haemodialysis patients. Nephrol. Dial. Transplant. 2002, 77 (3), 422-427.
7. Mydlík, M.; Derzsiova, K.; Racz, O.; Sipulova, A.; Lovasova, E.; Petrovicova, J. A modified dialyzer with vitamin E and antioxidant defense parameters. Kidney Int. 2001, 78 (Suppl.), S144-S147.
8. Costello, J.F.; Cottington, E.M. Plasma oxalate levels in hemodialysis patients despite increased oxalate removal. J. Am. Soc. Nephrol. 1991, 1 (12), 1289-1298.
9. Lim, P.S.; Wei, Y.H.; Yu, Y.L.; Kho, B. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol. Dial. Transplant. 1999, 14 (11), 2680-2687.
10. Roob, J.M.; Khoschsorur, G.; Tiran, A.; Horina, J.H.; Holzer, H.; Winklhofer-Roob, B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on haemodialysis. J. Am. Soc. Nephrol. 2000, 11 (3), 539-549.